drugset / Trial / NCT02920359

Generation of Positive Biological Samples to Leuprolide Acetate for Doping Control

NCT02920359

Phase 1 Completed 5 enrolled Parc de Salut Mar
NaSingle-groupOpen-labelBasic science

Summary

The study consists of the generation of biological samples (in urine) positive to leuprorelin acetate for doping control by new developed methods, and establish the analytical parameters that reveal the administration of Leuprorelin acetate in healthy volunteers with these methods.

Timeline

Start
2016-11-17
Primary completion
2016-12-13
Completion
2017-09-30

Drugs

EvaluationDrugModalityDoseRoute
Background Leuprolide Other / unclassified

Indications

No indication recorded.